West Virginia § 60B-1-3 Eligible drugs

West Virginia Statutes

§ 60B-1-3 — Eligible drugs

West Virginia § 60B-1-3

Ch. 60BDONATED DRUG REPOSITORY PROGRAM

This text of West Virginia § 60B-1-3 (Eligible drugs) is published on Counsel Stack Legal Research, covering West Virginia primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

W. Va. Code § 60B-1-3 (2026).

Text

(a)Drugs may only be dispensed pursuant to the program if:

(1)For prescription drugs, they do not expire before the completion of the medication by the eligible patient based on the prescribing health care professional’s directions for use and, for over-the-counter drugs, they do not expire before use by the eligible patient based on the directions for use on the manufacturer’s label; and

(2)The drugs were donated in unopened tamper-evident packaging as defined by United States Pharmacopeia General Chapter 659, Packaging and Storage Requirements, including, but not limited to, unopened unit-dose and multiple-dose packaging.

(b)The following drugs may not be donated to the program:

(1)Controlled substances;

(2)Drugs subject to a federal Food and Drug Administration managed risk e

Free access — add to your briefcase to read the full text and ask questions with AI

(a) Drugs may only be dispensed pursuant to the program if:

(1) For prescription drugs, they do not expire before the completion of the medication by the eligible patient based on the prescribing health care professional’s directions for use and, for over-the-counter drugs, they do not expire before use by the eligible patient based on the directions for use on the manufacturer’s label; and

(2) The drugs were donated in unopened tamper-evident packaging as defined by United States Pharmacopeia General Chapter 659, Packaging and Storage Requirements, including, but not limited to, unopened unit-dose and multiple-dose packaging.

(b) The following drugs may not be donated to the program:

(1) Controlled substances;

(2) Drugs subject to a federal Food and Drug Administration managed risk evaluation and mitigation strategy pursuant to 21 U.S.C. §355-1 if inventory transfer is prohibited by such strategy; or

(3) Drugs that there is reason to believe are adulterated.